Intensity Therapeutics, Inc. (INTS)

Intensity Therapeutics Statistics

Total Valuation

INTS has a market cap or net worth of $22.82 million. The enterprise value is $15.88 million.

Market Cap	22.82M
Enterprise Value	15.88M

Important Dates

The last earnings date was Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

INTS has 60.06 million shares outstanding. The number of shares has increased by 66.92% in one year.

Current Share Class	60.06M
Shares Outstanding	60.06M
Shares Change (YoY)	+66.92%
Shares Change (QoQ)	+128.12%
Owned by Insiders (%)	5.86%
Owned by Institutions (%)	6.98%
Float	53.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.58
P/TBV Ratio	3.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.60, with a Debt / Equity ratio of 0.02.

Current Ratio	3.60
Quick Ratio	3.11
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -234.70% and return on invested capital (ROIC) is -146.57%.

Return on Equity (ROE)	-234.70%
Return on Assets (ROA)	-101.66%
Return on Invested Capital (ROIC)	-146.57%
Return on Capital Employed (ROCE)	-164.66%
Revenue Per Employee	n/a
Profits Per Employee	-$1.68M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.33% in the last 52 weeks. The beta is 4.06, so INTS's price volatility has been higher than the market average.

Beta (5Y)	4.06
52-Week Price Change	-87.33%
50-Day Moving Average	0.35
200-Day Moving Average	0.82
Relative Strength Index (RSI)	47.69
Average Volume (20 Days)	87,537,561

Short Selling Information

The latest short interest is 16.77 million, so 27.92% of the outstanding shares have been sold short.

Short Interest	16.77M
Short Previous Month	2.25M
Short % of Shares Out	27.92%
Short % of Float	31.15%
Short Ratio (days to cover)	0.59

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.04M
Pretax Income	-11.74M
Net Income	-11.74M
EBITDA	n/a
EBIT	-12.04M
Earnings Per Share (EPS)	-$0.51

Balance Sheet

The company has $7.07 million in cash and $118,000 in debt, giving a net cash position of $6.95 million or $0.12 per share.

Cash & Cash Equivalents	7.07M
Total Debt	118,000
Net Cash	6.95M
Net Cash Per Share	$0.12
Equity (Book Value)	7.22M
Book Value Per Share	0.15
Working Capital	5.91M

Cash Flow

Operating Cash Flow	-9.50M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

INTS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-66.92%
Shareholder Yield	-66.92%
Earnings Yield	-51.42%
FCF Yield	n/a

Analyst Forecast

The average price target for INTS is $4.50, which is 1,084.21% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.50
Price Target Difference	1,084.21%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2